FDA rushed out agency-wide AI tool—it’s not going well - Ars Technica

Read also:

• FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a - Merck.com
• Are there any good YA romantasy/regular romance books for Christians? (preferably romantasy if possible)
• Ethereum faces macro crisis: Can ETH’s $2K hold? – KEY insights reveal… - AMBCrypto
• Can supporters of gun control explain the purpose behind a gun registry?
• Will norovirus surge early again this year? CDC urges tracking of new strain. - CBS News
• Report: Women's sports athletes to file appeal on House vs. NCAA settlement citing Title IX violations - On3.com
• Meta in Talks for Scale AI Investment That Could Top $10 Billion - Bloomberg
• Does coffee boost longevity? New study may have findings for people in midlife - San Francisco Chronicle
• 'Razor blade throat': Answers to questions about the new COVID variant - Hays Post
• Bettor banned for heckling Olympic star Thomas - ESPN
• WWE monitoring US-Iran situation with two Saudi Arabia shows set for next weekend - New York Post
• What is your most erotic sex story?
• iFixit says the Switch 2 is even harder to repair than the original - The Verge